iSpecimen
ISPC
9 hedge funds and large institutions have $32.9K invested in iSpecimen in 2025 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
0.12% less ownership
Funds ownership: 0.15% → 0.03% (-0.12%)
10% less funds holding
Funds holding: 10 → 9 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
93% less capital invested
Capital invested by funds: $443K → $32.9K (-$410K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$9.55K |
| 2 |
JF
Jump Financial
Chicago,
Illinois
|
+$6.64K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.08K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.74K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$25 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$198K |
| 2 |
VF
Virtu Financial
New York
|
-$82K |
| 3 |
SRL
Scientech Research LLC
Jersey City,
New Jersey
|
-$38K |
| 4 |
Jane Street
New York
|
-$3.9K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$387 |
ISPC Hedge Fund Activity: Q4 2025 in Review
9 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q4 2025, worth a combined $32.9K — down 93% from $443K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of ISPC and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $9.55K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $198K sold.
- 9 institutional investors held iSpecimen (ISPC) as of Q4 2025, down from 10 in Q3 2025.
- Funds reported $32.9K of iSpecimen stock for Q4 2025, down 93% quarter-over-quarter.
- 3 funds opened new iSpecimen positions in Q4 2025 and 4 closed out, a net change of -1 holder.
- The largest iSpecimen buyer in Q4 2025 was Susquehanna International Group, an estimated $9.55K added.
- The largest iSpecimen seller in Q4 2025 was Renaissance Technologies, an estimated $198K sold.
Based on aggregated 13F filings for Q4 2025.